• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

CD133 在结肠癌微小囊泡形成和癌蛋白转运中的作用。

Roles of CD133 in microvesicle formation and oncoprotein trafficking in colon cancer.

机构信息

Division of Life Sciences, Korea University, Seoul, South Korea.

出版信息

FASEB J. 2019 Mar;33(3):4248-4260. doi: 10.1096/fj.201802018R. Epub 2018 Dec 6.

DOI:10.1096/fj.201802018R
PMID:30521383
Abstract

Extracellular vesicles contain various cellular components that are involved in tumor growth, metastasis, and immune escape. Extracellular vesicles are classified into 2 groups, namely, exosomes and microvesicles (MV). Although the formation and roles of exosomes have been studied, the exact functions of MVs and mechanisms underlying MV release are not fully understood. We found that epidermal growth factor accelerates the release of MVs from the plasma membrane by inducing NF-κB activation and CD133 expression. The amount and sizes of budding MVs were found to be dependent on the expression level of CD133, which regulates the activities of the small guanosine 5'-triphosphatases RhoA and Rac1. CD133-containing MVs released from KRAS mutant colon cancer cells delivered KRAS mutant to adjacent nontumorigenic cells and activated KRAS downstream signaling. CD133-containing MVs were found to promote the migration and invasion of adjacent cells. CD133-containing MVs induced the development of chemoresistance by abolishing the inhibitory effects of anti-epidermal growth factor receptor (EGFR) drugs on cell proliferation and motility in colon cancer. These results suggest that CD133 acts as a novel modulator in MV release and in oncoprotein trafficking. CD133 can serve as a therapeutic target for treatment of anti-EGFR drug-resistant colon cancer.-Kang, M., Kim, S., Ko, J. Roles of CD133 in microvesicle formation and oncoprotein trafficking in colon cancer.

摘要

细胞外囊泡包含各种参与肿瘤生长、转移和免疫逃逸的细胞成分。细胞外囊泡分为 2 组,即外泌体和微泡(MV)。尽管已经研究了外泌体的形成和作用,但 MV 的确切功能和 MV 释放的机制尚不完全清楚。我们发现表皮生长因子通过诱导 NF-κB 激活和 CD133 表达来加速 MV 从质膜释放。发现出芽 MV 的数量和大小取决于 CD133 的表达水平,CD133 调节小 GTP 酶 RhoA 和 Rac1 的活性。从 KRAS 突变结肠癌细胞释放的含有 CD133 的 MV 将 KRAS 突变体递送到相邻的非致瘤细胞,并激活 KRAS 下游信号。发现含有 CD133 的 MV 促进了相邻细胞的迁移和侵袭。含有 CD133 的 MV 通过消除抗表皮生长因子受体(EGFR)药物对结肠癌细胞增殖和运动的抑制作用,导致化学耐药性的发展。这些结果表明 CD133 作为 MV 释放和癌蛋白转运的新型调节剂发挥作用。CD133 可以作为治疗抗 EGFR 药物耐药性结肠癌的靶点。-Kang,M.,Kim,S.,Ko,J. CD133 在结肠癌细胞中 MV 形成和癌蛋白转运中的作用。

相似文献

1
Roles of CD133 in microvesicle formation and oncoprotein trafficking in colon cancer.CD133 在结肠癌微小囊泡形成和癌蛋白转运中的作用。
FASEB J. 2019 Mar;33(3):4248-4260. doi: 10.1096/fj.201802018R. Epub 2018 Dec 6.
2
CD133-containing microvesicles promote cancer progression by inducing M2-like tumor-associated macrophage polarization in the tumor microenvironment of colorectal cancer.CD133 阳性微囊泡通过诱导结直肠癌肿瘤微环境中的 M2 样肿瘤相关巨噬细胞极化促进肿瘤进展。
Carcinogenesis. 2024 May 19;45(5):300-310. doi: 10.1093/carcin/bgad093.
3
CD133-containing microvesicles promote colorectal cancer progression by inducing tumor angiogenesis.含CD133的微泡通过诱导肿瘤血管生成促进结直肠癌进展。
Heliyon. 2024 Apr 4;10(7):e29292. doi: 10.1016/j.heliyon.2024.e29292. eCollection 2024 Apr 15.
4
Differentiation Affects the Release of Exosomes from Colon Cancer Cells and Their Ability to Modulate the Behavior of Recipient Cells.分化影响结肠癌细胞外泌体的释放及其调节受体细胞行为的能力。
Am J Pathol. 2017 Jul;187(7):1633-1647. doi: 10.1016/j.ajpath.2017.03.015. Epub 2017 Jun 12.
5
Silencing of CD133 inhibits GLUT1-mediated glucose transport through downregulation of the HER3/Akt/mTOR pathway in colon cancer.沉默 CD133 通过下调 HER3/Akt/mTOR 通路抑制结肠癌细胞中 GLUT1 介导的葡萄糖转运。
FEBS Lett. 2020 Mar;594(6):1021-1035. doi: 10.1002/1873-3468.13686. Epub 2019 Nov 29.
6
CD63 Regulates Epstein-Barr Virus LMP1 Exosomal Packaging, Enhancement of Vesicle Production, and Noncanonical NF-κB Signaling.CD63调节爱泼斯坦-巴尔病毒潜伏膜蛋白1的外泌体包装、囊泡产生增强及非经典核因子κB信号传导。
J Virol. 2017 Feb 14;91(5). doi: 10.1128/JVI.02251-16. Print 2017 Mar 1.
7
Exosomes from metastatic colon cancer cells drive the proliferation and migration of primary colon cancer through increased expression of cancer stem cell markers CD133 and DCLK1.转移性结肠癌细胞来源的外泌体通过增加癌症干细胞标志物 CD133 和 DCLK1 的表达来驱动原发性结肠癌细胞的增殖和迁移。
Tissue Cell. 2023 Oct;84:102163. doi: 10.1016/j.tice.2023.102163. Epub 2023 Jul 13.
8
Inhibition of CREB binding protein-beta-catenin signaling down regulates CD133 expression and activates PP2A-PTEN signaling in tumor initiating liver cancer cells.抑制 CREB 结合蛋白-β-连环蛋白信号通路可下调肿瘤起始性肝癌细胞中 CD133 的表达,并激活 PP2A-PTEN 信号通路。
Cell Commun Signal. 2018 Mar 12;16(1):9. doi: 10.1186/s12964-018-0222-5.
9
The HDAC6 Inhibitor Tubacin Induces Release of CD133 Extracellular Vesicles From Cancer Cells.组蛋白去乙酰化酶6抑制剂Tubacin诱导癌细胞释放CD133细胞外囊泡。
J Cell Biochem. 2017 Dec;118(12):4414-4424. doi: 10.1002/jcb.26095. Epub 2017 May 31.
10
Pancreatic Tumor Progression Associated With CD133 Overexpression: Involvement of Increased TERT Expression and Epidermal Growth Factor Receptor-Dependent Akt Activation.与CD133过表达相关的胰腺肿瘤进展:端粒酶逆转录酶(TERT)表达增加及表皮生长因子受体依赖性Akt激活的参与
Pancreas. 2016 Mar;45(3):443-57. doi: 10.1097/MPA.0000000000000460.

引用本文的文献

1
Protrusion-Derived Extracellular Vesicles (PD-EVs) and Their Diverse Origins: Key Players in Cellular Communication, Cancer Progression, and T Cell Modulation.突起衍生的细胞外囊泡(PD-EVs)及其多样起源:细胞通讯、癌症进展和T细胞调节中的关键参与者
Biol Cell. 2025 Jun;117(6):e70018. doi: 10.1111/boc.70018.
2
A Planar-Gate Graphene Field-Effect Transistor Integrated Portable Platform for Rapid Detection of Colon Cancer-Derived Exosomes.一种用于快速检测结肠癌衍生外泌体的平面栅极石墨烯场效应晶体管集成便携式平台。
Biosensors (Basel). 2025 Mar 24;15(4):207. doi: 10.3390/bios15040207.
3
N6-methyladenosine RNA modified BAIAP2L2 facilitates extracellular vesicles-mediated chemoresistance transmission in gastric cancer.
N6-甲基腺苷RNA修饰的BAIAP2L2促进细胞外囊泡介导的胃癌化疗耐药性传递。
J Transl Med. 2025 Mar 13;23(1):320. doi: 10.1186/s12967-025-06340-6.
4
Extracellular Vesicles as Mediators and Potential Targets in Combating Cancer Drug Resistance.细胞外囊泡作为对抗癌症耐药性的介质和潜在靶点。
Molecules. 2025 Jan 23;30(3):498. doi: 10.3390/molecules30030498.
5
Prominosomes - a particular class of extracellular vesicles containing prominin-1/CD133?突起小体——一类含有prominin-1/CD133的特殊细胞外囊泡?
J Nanobiotechnology. 2025 Jan 29;23(1):61. doi: 10.1186/s12951-025-03102-w.
6
Proteome characterization of extracellular vesicles from human milk: Uncovering the surfaceome by a lipid-based protein immobilization technology.人乳细胞外囊泡的蛋白质组表征:通过基于脂质的蛋白质固定技术揭示表面蛋白质组。
J Extracell Biol. 2024 Nov 7;3(11):e70020. doi: 10.1002/jex2.70020. eCollection 2024 Nov.
7
Nanobiotechnology augmented cancer stem cell guided management of cancer: liquid-biopsy, imaging, and treatment.纳米生物技术增强癌症干细胞指导下的癌症管理:液体活检、成像和治疗。
J Nanobiotechnology. 2024 Apr 12;22(1):176. doi: 10.1186/s12951-024-02432-5.
8
CD133-containing microvesicles promote colorectal cancer progression by inducing tumor angiogenesis.含CD133的微泡通过诱导肿瘤血管生成促进结直肠癌进展。
Heliyon. 2024 Apr 4;10(7):e29292. doi: 10.1016/j.heliyon.2024.e29292. eCollection 2024 Apr 15.
9
Aberrant stem cell and developmental programs in pediatric leukemia.小儿白血病中的异常干细胞和发育程序
Front Cell Dev Biol. 2024 Mar 27;12:1372899. doi: 10.3389/fcell.2024.1372899. eCollection 2024.
10
Emerging roles of prominin-1 (CD133) in the dynamics of plasma membrane architecture and cell signaling pathways in health and disease.Prominin-1(CD133)在健康和疾病中参与质膜结构和细胞信号通路动态变化的新兴作用。
Cell Mol Biol Lett. 2024 Mar 26;29(1):41. doi: 10.1186/s11658-024-00554-0.